Science News: ISC Late Breaking Oral Abstracts

International Stroke Conference 2015
February 10–15, 2015 | Nashville, Tenn.

Wednesday's Late Breaking Oral Abstracts


EXTEND-IA
Bruce. C. Campbell, MD, discusses the findings of his study, Endovascular Therapy After Intravenous t-PA Versus t-PA Alone For Ischemic Stroke Using CT Perfusion Imaging Selection.


ESCAPE
Kyra Becker, MD, program committee chair, interviews Michael Hill, MD, principle investigator, about the results of the ESCAPE trial.

Plenary Session I

LB1. Endovascular treatment for Small Core and Anterior circulation Proximal occlusion with Emphasis on minimizing CT to recanalization times (ESCAPE)
Michael D Hill, University of Calgary, Calgary, AB, Canada


LB2 - EXTEND-IA - Endovascular Therapy After Intravenous t-PA Versus t-PA Alone For Ischemic Stroke Using CT Perfusion Imaging Selection
Bruce C Campbell, Royal Melbourne Hospital, Parkville, Australia


MR CLEAN: High Level Results
Yvo Roos, Academic Medical Center, Amsterdam, Netherlands


SWIFT PRIME Results
Jeffrey L Saver, Geffen School of Medicine at UCLA, Los Angeles, CA


 

Thursday's Late Breaking Oral Abstracts


Review of LB4, LB5, LB14
Joe Broderick, MD, Ayesha Sherzai, MD, and Jesse Dawson, MD, provide an overview of the science they presented Thursday.


JPPP: Aspirin Showed No Benefit for Primary Prevention of Stroke in Elderly Japanese
Shinichiro Uchiyama, MD provides an overview of the results of the JPPP trial, which he presented Thursday afternoon.

Plenary Session II

LB3 - Cervical Artery Dissection in Stroke Study (CADISS)
Hugh S Markus, University of Cambridge, Cambridge, United Kingdom


LB4 - Pooled Analysis Of The IMS III And MR CLEAN Trials For Patients With NIHSS Of 20 Or More 
Joseph Broderick, University of Cincinnati, Cincinnati, OH


LB5 - Mediterranean Diet and Incidence of Stroke in the California Teachers Study
Ayesha Z Sherzai, Columbia University, New York, NY


LB6 - Effects of Immediate Blood Pressure Reduction on One Year Mortality and Major Disability in Patients with Acute Ischemic Stroke 
Jiang He, Tulane University, New Orleans, LA


LB7 - Endovascular Treatment Compared With Medical Treatment in Patients with Acute Ischemic Stroke: A meta-analysis of 1561 patients
Adnan I Qureshi, Zeenat Qureshi Stroke Institute, St. Cloud, MN


LB18 - Time To Reperfusion And Effect Of Intra-arterial Treatment In The Mr Clean Trial
Puck S Fransen, Erasmus MC University Medical Center of Rotterdam, Rotterdam, Netherlands

 

More Late Breaking Oral Abstracts

LB8 - Efficacy And Safety of Aspirin For Primary Stroke Prevention In Elderly Patients With Vascular Risk Factors: Subanalysis Of Japanese Primary Prevention Project (jppp) 
Shinichiro Uchiyama, Clinical Research Center for Medicine, International University of Health and Welfare, Tokyo, Japan


LB9 - Impact of Hemodynamics on Stroke Risk in Symptomatic Vertebrobasilar Disease: Results of the VERiTAS Study 
Sepideh Amin-Hanjani, University of Illinois at Chicago, Chicago, IL


LB10 - Number Needed to Treat to Benefit and Harm for Endovascular Therapy in Acute Ischemic Stroke: Joint Outcome Table Analysis of the MR CLEAN Trial 
May Nour, University of California at Los Angeles, Los Angeles, CA


LB11 - Device Closure In Patent Foramen Ovale And Stroke: A Meta-analysis Of Individual Patient Data From Randomized Trials
David M Kent, Tufts Medical Center, Boston, MA


LB12 - The Safety and Efficacy of Image- Guided Tran-sulcal Radial Corridors For Hematoma Evacuation: A Multicenter Study
Mohamed Labib, University of Ottawa, Ottawa, ON, Canada


LB13 - Increased P-Wave Terminal Force in Lead V1 Predicts Cryptogenic and Cardioembolic Strokes: The Northern Manhattan Study 
Madeleine D. Hunter, Columbia University, New York, NY


LB14 - Vagus Nerve Stimulation Paired with Rehabilitation Improves Upper Limb Recovery after Chronic Ischemic Stroke 
Jesse D Dawson, University of Glasgow, Glasgow, United Kingdom


Friday's Late Breaking Oral Abstracts


ICARE: Primary Results
Bruce Ovbiagele, MD interviews Carolee Winstein, MD about the results of the ICARE study.


J-STARS--Statin Treatment for Recurrent Stroke Prevention
Bruce Ovbiagele, MD, program vice chair for the International Stroke Conference 2015, interviews Masayasu Matsamoto, MD, principle investigator for J-STARS about the results he presented during the meeting.

Plenary Session III

LB15 - ICARE Primary Results: A Phase III Stroke Rehabilitation Trial
Carolee J Winstein, University of Southern California, Los Angeles, CA


LB16 - The Japan Statin Treatment Against Recurrent Stroke (J-STARS): a multicenter, randomized, open-label, parallel-group study
Masayasu Matsumoto, Hiroshima University Graduate School of Biomedical and Health Sciences, Hiroshima, Japan


LB17 - Impact Of General Anaesthesia On Treatment Effect In The MR CLEAN Trial
Olvert A Berkhemer, Academic Medical Center, Amsterdam, Netherlands


REVASCAT Results
Tudor Jovin, University of Pittsburgh Medical Center, Pittsburgh, PA